Reduced expression of E-cadherin in oral squamous cell carcinoma: Relationship with DNA methylation of 5′ CpG island

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 293-298

  Saito, Yoshiaki ^a   Takazawa, Hiroshi ^b   Uzawa, Katsuhiro ^a   Tanzawa, Hideki ^a   Sato, Kenichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

CpG methylalion; E cadherin; Gene mutation; Immunohistochemistry; Oral squamous cell carcinoma

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER INVASION; CANCER SURGERY; CELL DIFFERENTIATION; DNA DETERMINATION; DNA METHYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2;

EID: 0031909379     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.293     Document Type: Article

References (29)

1. Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219-229, 1993.
2. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
3. Fixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmerier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
4. Dorudi S, Sheffield JP, Poulsom R, Northover JMA and Hart LR: E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993.
5. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
6. Oka H, Shiozaki H, Kobayashi K,Tahara H, Tamura S, Miyata M, Doki Y, Iibara K, Matsuyoshi N, Hirano S, Takeichi M and Mori T: Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 421: 149-156, 1992.
7. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996.
8. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ and Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
9. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsukita S and Mori T: E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54: 291-296, 1994.
10. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, Hor-Grootenboer BV, deMulder PHM and Ruiter DJ: E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55: 580-585, 1993.
11. Schipper JH, Fixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
12. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Höfler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
13. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H and Hirohashi S: E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 87: 843-848, 1996.
14. Risinger JI, Berchuck A, Kohler MF and Boyd J: Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7: 98-102, 1994.
15. Kanai Y, Oda T, Tsuda H, Ochiai A and Hirohashi S: Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85: 1035-1039, 1994.
16. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJF, van de Vijver MJ, Cornelisse C and van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6105, 1995.
17. Oda T, Kanai Y, Oyama T, Yoshiura K Shimoyama Y Birchmeier W, Sugimura T and Hirohashi S: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
18. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199, 1995.
19. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419, 1995.
20. Uzawa K, Yoshida H, Suzuki H, Tanzawa H, Shimazaki J, Seino S and Sato S: Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer 58: 814-817, 1994.
21. Vessey CJ, Wilding J, Polarin N, Hirano S, Takeichi M, Soutter P, Stamp GWH and Pignatelli M: Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 176: 151-159, 1995.
22. Crissman JD, Liu WY, Gluckman JL and Cummings G: Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 54: 2995-3001, 1984.
23. Ritter M, de Kant E, Huhn D and Neubauer A: Detection of DNA methylation in the calcitonin gene in human leukemias using differential polymerase chain reaction. Leukemia 9: 915-921, 1995.
24. Bussemakers MJG, Giroldi LA, van Bokhoven A and Schalken JA: Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines. Biochem Biophys Res Commun 203: 1284-1290, 1994.
25. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirlo L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M and White R: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600, 1991.
26. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T and Hirohashi S: Allelic loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791-6794, 1990.
27. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burgwe PC, Baylin SB and Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
28. D'Souza B and Taylor-Papadimitriou J: Overexpression of ERB B2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91: 7202-7206, 1994.
29. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yamamoto M and Kato I: Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69: 580-585, 1994.